Loading…

Diffusion tensor imaging of the brain in Pompe disease

Enzyme replacement therapy has drastically changed prospects of patients with Pompe disease, a progressive metabolic myopathy. As classic infantile patients survive due to treatment, they exhibit progressive white matter abnormalities, while brain involvement in late-onset patients is not fully eluc...

Full description

Saved in:
Bibliographic Details
Published in:Journal of neurology 2023-03, Vol.270 (3), p.1662-1671
Main Authors: van den Dorpel, Jan J. A., Dremmen, Marjolein H. G., van der Beek, Nadine A. M. E., Rizopoulos, Dimitris, van Doorn, Pieter A., van der Ploeg, Ans T., Muetzel, Ryan L., van den Hout, Johanna M. P.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Enzyme replacement therapy has drastically changed prospects of patients with Pompe disease, a progressive metabolic myopathy. As classic infantile patients survive due to treatment, they exhibit progressive white matter abnormalities, while brain involvement in late-onset patients is not fully elucidated. To study the underlying microstructure of white matter, we acquired structural (T1, T2, FLAIR) and diffusion tensor imaging (DTI) of the brain in 12 classic infantile patients (age 5–20 years) and 18 late-onset Pompe patients (age 11–56 years). Structural images were scored according to a rating scale for classic infantile patients. Fractional anisotropy (FA) and mean diffusivity (MD) from classic infantile patients were compared to a reference population, using a Wilcoxon signed-rank, one sample test. Effect sizes (Hedges’ G) were used to compare DTI metrics across different tracts. For late-onset patients, results were compared to (reported) tractography data on normal aging. In classic infantile patients, we found a significant lower FA and higher MD ( p  
ISSN:0340-5354
1432-1459
DOI:10.1007/s00415-022-11506-z